Cancer BiologybioRxivPreprint
A novel antibody targeting ICOS increases intratumoural cytotoxic to regulatory T cell ratio and induces tumour regression.
R. C. A. Sainson, A. K. Thotakura, M. Kosmac…·M. McCourt
This paper develops an antibody targeting ICOS that improves the TEFF:TReg ratio and induces tumour regression in preclinical models.
DOI 10.1101/771493